Photoactivatable drugs for nicotinic optopharmacology

Nat Methods. 2018 May;15(5):347-350. doi: 10.1038/nmeth.4637. Epub 2018 Mar 26.

Abstract

Photoactivatable pharmacological agents have revolutionized neuroscience, but the palette of available compounds is limited. We describe a general method for caging tertiary amines by using a stable quaternary ammonium linkage that elicits a red shift in the activation wavelength. We prepared a photoactivatable nicotine (PA-Nic), uncageable via one- or two-photon excitation, that is useful to study nicotinic acetylcholine receptors (nAChRs) in different experimental preparations and spatiotemporal scales.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / drug effects
  • Brain / metabolism
  • Calcium
  • Immunohistochemistry
  • Mice
  • Microscopy, Confocal
  • Nicotine / pharmacology*
  • Photochemical Processes*
  • Receptors, Nicotinic / physiology*
  • Spectrometry, Fluorescence
  • Spectrophotometry, Ultraviolet

Substances

  • Receptors, Nicotinic
  • Nicotine
  • Calcium